A citation-based method for searching scientific literature

Louise Wideroff, Andrew N Freedman, Lorayn Olson, Carrie N Klabunde, William Davis, Kadaba P Srinath, Robert T Croyle, Rachel Ballard-Barbash. Cancer Epidemiol Biomarkers Prev 2003
Times Cited: 104







List of co-cited articles
516 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


US physicians' attitudes toward genetic testing for cancer susceptibility.
A N Freedman, L Wideroff, L Olson, W Davis, C Klabunde, K P Srinath, B B Reeve, R T Croyle, R Ballard-Barbash. Am J Med Genet A 2003
134
37

Use of cancer susceptibility testing among primary care physicians.
R Sifri, R Myers, T Hyslop, B Turner, J Cocroft, T Rothermel, J Grana, N Schlackman. Clin Genet 2003
40
47


Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics.
R T Acton, N M Burst, L Casebeer, S M Ferguson, P Greene, B L Laird, L Leviton. Acad Med 2000
111
15

Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.
L Wideroff, S T Vadaparampil, M H Greene, S Taplin, L Olson, A N Freedman. J Med Genet 2005
110
15




Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
477
11

Identification and referral of families at high risk for cancer susceptibility.
Kevin M Sweet, Terry L Bradley, Judith A Westman. J Clin Oncol 2002
128
11

Primary care physicians' attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results.
Lois C Friedman, H Paul Cooper, John A Webb, Armin D Weinberg, Sharon E Plon. J Cancer Educ 2003
28
39


Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
113
11

Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location.
Christine E Koil, Jessica N Everett, Leah Hoechstetter, Rick E Ricer, Karen M Huelsman. Genet Med 2003
34
29



Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Katrina F Trivers, Laura-Mae Baldwin, Jacqueline W Miller, Barbara Matthews, C Holly A Andrilla, Denise M Lishner, Barbara A Goff. Cancer 2011
77
12

Genetic testing: a physician's perspective.
J D Menasha, C Schechter, J Willner. Mt Sinai J Med 2000
42
21

The use and interpretation of commercial APC gene testing for familial adenomatous polyposis.
F M Giardiello, J D Brensinger, G M Petersen, M C Luce, L M Hylind, J A Bacon, S V Booker, R D Parker, S R Hamilton. N Engl J Med 1997
333
9

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
9

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
8

Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns.
Paul C Schroy, Adam F Barrison, Bruce S Ling, Sheila Wilson, Adam C Geller. Am J Gastroenterol 2002
111
8

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
8

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
867
8

Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
Angela Trepanier, Mary Ahrens, Wendy McKinnon, June Peters, Jill Stopfer, Sherry Campbell Grumet, Susan Manley, Julie O Culver, Ronald Acton, Joy Larsen-Haidle,[...]. J Genet Couns 2004
145
8

Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology.
Shivani Batra, Heiddis Valdimarsdottir, Margaret McGovern, Steven Itzkowitz, Karen Brown. Am J Gastroenterol 2002
56
14

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
288
8

Genetic susceptibility to cancer. Family physicians' experience.
June C Carroll, Judith Belle Brown, Sean Blaine, Gord Glendon, Patricia Pugh, Wendy Medved. Can Fam Physician 2003
51
15

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
8

Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians.
Della Brown White, Vence L Bonham, Jean Jenkins, Nancy Stevens, Colleen M McBride. Cancer Epidemiol Biomarkers Prev 2008
36
22

Errors in delivery of cancer genetics services: implications for practice.
Karina L Brierley, Danielle Campfield, Whitney Ducaine, Lindsay Dohany, Talia Donenberg, Kristen Shannon, Robin C Schwartz, Ellen T Matloff. Conn Med 2010
67
11

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
7

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
W Burke, M Daly, J Garber, J Botkin, M J Kahn, P Lynch, A McTiernan, K Offit, J Perlman, G Petersen,[...]. JAMA 1997
697
7

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
Lauren Scheuer, Noah Kauff, Mark Robson, Bridget Kelly, Richard Barakat, Jaya Satagopan, Nathan Ellis, Martee Hensley, Jeff Boyd, Patrick Borgen,[...]. J Clin Oncol 2002
307
7

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
7


Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment.
Judy Mouchawar, Sharon Hensley-Alford, Suzanne Laurion, Jennifer Ellis, Alanna Kulchak-Rahm, Melissa L Finucane, Richard Meenan, Lisen Axell, Rebecca Pollack, Debra Ritzwoller. Genet Med 2005
68
10


Physicians' experiences with BRCA1/2 testing in community settings.
Nancy L Keating, Kathryn A Stoeckert, Meredith M Regan, Lisa DiGianni, Judy E Garber. J Clin Oncol 2008
31
22

Delivery of genomic medicine for common chronic adult diseases: a systematic review.
Maren T Scheuner, Pauline Sieverding, Paul G Shekelle. JAMA 2008
213
7

Genetic assessment of breast cancer risk in primary care practice.
Wylie Burke, Julie Culver, Linda Pinsky, Sarah Hall, Susan E Reynolds, Yutaka Yasui, Nancy Press. Am J Med Genet A 2009
53
13

Physicians' attitudes about multiplex tumor genomic testing.
Stacy W Gray, Katherine Hicks-Courant, Angel Cronin, Barrett J Rollins, Jane C Weeks. J Clin Oncol 2014
145
7

Obstetrician-gynecologists' opinions and attitudes on the role of genetics in women's health.
L Wilkins-Haug, K Erickson, L Hill, M Power, G B Holzman, J Schulkin. J Womens Health Gend Based Med 2000
41
14

Limitations of direct-to-consumer advertising for clinical genetic testing.
Sarah E Gollust, Sara Chandros Hull, Benjamin S Wilfond. JAMA 2002
115
6

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
6

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer, B van Geel, W L van Putten, S C Henzen-Logmans, C Seynaeve, M B Menke-Pluymers, C C Bartels, L C Verhoog, A M van den Ouweland, M F Niermeijer,[...]. N Engl J Med 2001
631
6


Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J J√§rvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltom√§ki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
923
6

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
116
6

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
702
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.